Beyond the Abstract - FOCUS on FOCIS: Combined Chemo-Immunotherapy for the Treatment of Hormone-Refractory Metastatic Prostate Cancer
BERKELEY, CA (UroToday.com) - The long-term goal of the Tumor Immunology and Immunotherapy group at The Institute of Immunology, Charles University, 2nd Medical School is the development of dendritic cell-based cancer vaccine.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
